+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Recreational Cannabis"

Paraguay: CBD and Cannabis Regulation - Product Thumbnail Image

Paraguay: CBD and Cannabis Regulation

  • Report
  • May 2022
  • 20 Pages
  • Paraguay
UK: CBD and Cannabis Regulation - Product Thumbnail Image

UK: CBD and Cannabis Regulation

  • Report
  • May 2022
  • 18 Pages
  • United Kingdom
New Zealand: CBD and Cannabis Regulation - Product Thumbnail Image

New Zealand: CBD and Cannabis Regulation

  • Report
  • May 2022
  • 15 Pages
  • New Zealand
Argentina: CBD and Cannabis Regulation - Product Thumbnail Image

Argentina: CBD and Cannabis Regulation

  • Report
  • April 2022
  • 22 Pages
  • Argentina
Ireland: CBD and Cannabis Regulation - Product Thumbnail Image

Ireland: CBD and Cannabis Regulation

  • Report
  • April 2022
  • 21 Pages
  • Ireland
Brazil: CBD and Cannabis Regulation 2022 - Product Thumbnail Image

Brazil: CBD and Cannabis Regulation 2022

  • Report
  • March 2022
  • 15 Pages
  • Brazil
Regulatory Report: US State-by-State Taxation of Medical Cannabis - Product Thumbnail Image

Regulatory Report: US State-by-State Taxation of Medical Cannabis

  • Report
  • March 2022
  • 14 Pages
  • United States
Medical and Recreational Cannabis – A Global Overview - Product Thumbnail Image

Medical and Recreational Cannabis – A Global Overview

  • Report
  • March 2022
  • 10 Pages
  • Global
CBD Regulatory Report: Hemp Products Under California'S Assembly Bill 45 - Product Thumbnail Image

CBD Regulatory Report: Hemp Products Under California'S Assembly Bill 45

  • Report
  • February 2022
  • 12 Pages
  • United States
CBD Regulatory Report: Germany - Product Thumbnail Image

CBD Regulatory Report: Germany

  • Report
  • December 2021
  • 25 Pages
  • Germany
CBD and Cannabis Regulatory Report: Chile - Product Thumbnail Image

CBD and Cannabis Regulatory Report: Chile

  • Report
  • October 2021
  • 14 Pages
  • Chile
Latvia: CBD and Cannabis Regulation - Product Thumbnail Image

Latvia: CBD and Cannabis Regulation

  • Report
  • April 2023
  • 10 Pages
  • Latvia
Guyana: CBD and Cannabis Regulation - Product Thumbnail Image

Guyana: CBD and Cannabis Regulation

  • Report
  • April 2023
  • 15 Pages
  • Guyana
Australia: CBD and Cannabis Regulation - Product Thumbnail Image

Australia: CBD and Cannabis Regulation

  • Report
  • April 2023
  • 22 Pages
  • Australia
Global CBD Regulatory Database - Product Thumbnail Image

Global CBD Regulatory Database

  • Database
  • March 2023
  • Global
Serbia: CBD and Cannabis Regulation - Product Thumbnail Image

Serbia: CBD and Cannabis Regulation

  • Report
  • March 2023
  • 12 Pages
  • Serbia
Peru: CBD and Cannabis Regulation - Product Thumbnail Image

Peru: CBD and Cannabis Regulation

  • Report
  • March 2023
  • 15 Pages
  • Peru
Greece: CBD and Cannabis Regulation - Product Thumbnail Image

Greece: CBD and Cannabis Regulation

  • Report
  • March 2023
  • 18 Pages
  • Greece
Portugal: CBD and Cannabis Regulation - Product Thumbnail Image

Portugal: CBD and Cannabis Regulation

  • Report
  • March 2023
  • 15 Pages
  • Portugal
Loading Indicator

The recreational cannabis market has become a notable segment within the broader analgesics industry, as consumers increasingly seek alternatives to traditional over-the-counter and prescription pain relievers. Cannabis is touted for its pain-relieving properties, with THC and CBD being the most prominent constituents associated with analgesic effects. Recreational cannabis offers a dual benefit of alleviating pain and providing a pleasurable experience, which has led to its rising popularity where it is legally permitted. It is available in various forms, including but not limited to flower, edibles, oils, and topicals. Consumers can choose products based on desired effect, potency, and mode of consumption. The market's expansion is further driven by ongoing research and development aimed at understanding the therapeutic potential of cannabis and optimizing its use for pain management. Several companies have established their presence in the recreational cannabis market with a focus on analgesic products. Well-known players include Canopy Growth Corporation, Aurora Cannabis, and Tilray, all of which have extensive product lines and international reach. Other notable companies are Curaleaf and Cresco Labs, which have a strong presence in the United States. These companies are engaged in competitive strategies, including product innovation and mergers & acquisitions, to capture a larger share of the market. Show Less Read more